Pura Vida Investments, LLC Liquidia Corp Transaction History

Pura Vida Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.68 - $6.54 $1.54 Million - $2.15 Million	-329,335 Reduced 61.23%	208,535 $1.33 Million
Q3 2022 Nov 14, 2022	BUY	$3.73 - $8.39 $2.01 Million - $4.51 Million	537,870 New	537,870 $2.93 Million
Q2 2022 Aug 15, 2022	SELL	$3.37 - $7.55 $847,905 - $1.9 Million	-251,604 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.14 - $7.38 $1.03 Million - $1.48 Million	200,200 Added 389.46%	251,604 $1.81 Million
Q4 2021 Feb 14, 2022	BUY	$2.71 - $5.17 $139,304 - $265,758	51,404 New	51,404 $250,000
Q4 2020 Feb 16, 2021	SELL	$2.6 - $5.79 $260,000 - $579,000	-100,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.34 - $8.28 $217,000 - $413,999	-50,000 Reduced 33.33%	100,000 $492,000
Q2 2020 Aug 14, 2020	BUY	$4.86 - $11.44 $729,000 - $1.72 Million	150,000 New	150,000 $1.26 Million

162

36M

1.79M

380K

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.